ERBB2 and breast cancer: SK-BR-3 cells and DMBA-induced tumors, both with ER- and Her-2+ characteristics, were synergistically affected by DHA and CCM, which suggests that the specific breast cancer phenotype is an important factor for predicting efficacy.